Academic

STARTUP WILL OFFER PATIENTS a genetic profile of their cancer. ?Many cancer researchers believe tha?

By Glenn Reynolds

STARTUP WILL OFFER PATIENTS a genetic profile of their cancer. “Many cancer researchers believe that therapies could be more effective if they target genetic aberrations in a patient’s cancer. In recent years, there have been a handful of successes in targeting cancer treatments in this way: for example, the drug Herceptin can be effective in breast cancer patients with a specific mutation in the HER2 gene. But so far, this kind of targeted cancer treatment has been limited to a select few genetic mutations in specific cancers, even though most cancers derive from several genetic mutations in combination. Foundation Medicine wants to create a test that gives a comprehensive view of the genetic aberrations in a cancer sample.”

Full post as published by Instapundit.com on June 19, 2010 (boomark / email).